Inventor · disambiguated record
Mingjiu Chen
Also filed as: CHEN MINGJIU
5 granted patents·15 pending applications·0 citations·filing 2018–2024
61Inventor score
Files withBIOSION INC13IMMVIRA CO LTD2SALUBRIS CHENGDU BIOTECH CO LTD2BIOSION INC BIOSION INC1CELLDEX THERAPEUTICS INC1
Top patents by PatentIndex Score
20 records- 0172US12304955B2Antibodies binding PD-1 and uses thereofIMMVIRA CO LTD·Filed 2024·Granted May 20, 2025·0 cites·8 claims
- 0261US2024409639A1Anti-ilt4 and anti-pd-1 bispecific constructsCELLDEX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0358US2024002508A1Antibodies binding siglec15 and uses thereofBIOSION INC·Filed 2023·Application pending·0 cites
- 0458US2025109212A1Recombinant fusion protein targeting cd40 and cd47BIOSION INC·Filed 2023·Application pending·0 cites
- 0556US11739147B2Antibodies binding Siglec15 and uses thereofBIOSION INC BIOSION INC·Filed 2022·Granted Aug 29, 2023·0 cites·30 claims
- 0653US2025250355A1Antibodies targeting sirp-alpha and uses thereofBIOSION INC·Filed 2023·Application pending·0 cites
- 0750US2023105029A1Antibodies binding il4r and uses thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
- 0849US12037395B1Antibodies binding PD-1 and uses thereofIMMVIRA CO LTD·Filed 2019·Granted Jul 16, 2024·0 cites·10 claims
- 0948US12479912B2Monoclonal antibodies which bind thymic stromal lymphopoietin (TSLP), encoding polynucleotides thereof and methods of use thereof to treat diseasesBIOSION INC·Filed 2020·Granted Nov 25, 2025·0 cites·24 claims
- 1048US2023383007A1Nanobodies binding trop2 and uses thereofBIOSION INC·Filed 2021·Application pending·0 cites
- 1147US2025136678A1Antibodies binding cldn18.2 and uses thereofBIOSION INC·Filed 2022·Application pending·0 cites
- 1245US2024207432A1Antibodies binding trop2 and uses thereofBIOSION INC·Filed 2021·Application pending·0 cites
- 1345US2023055711A1Antibodies binding bcma and uses thereofBIOSION INC·Filed 2020·Application pending·0 cites
- 1444US2020332017A1Antibodies or antigen-binding portions binding cd40 and uses thereofSALUBRIS CHENGDU BIOTECH CO LTD·Filed 2020·Application pending·0 cites
- 1543US2023034768A1Antibodies binding rankl and uses thereofBIOSION INC·Filed 2020·Application pending·0 cites
- 1642US2023331848A1Pd-1 binding antibodies and uses thereofBIOSION INC·Filed 2021·Application pending·0 cites
- 1742US2021095032A1Antibodies binding pd-1 and uses thereofSALUBRIS CHENGDU BIOTECH CO LTD·Filed 2019·Application pending·0 cites
- 1841US11390685B2ErbB2 antibodies and uses thereforeBIOSION INC·Filed 2018·Granted Jul 19, 2022·0 cites·18 claims
- 1941US2023357438A1Antibodies binding c5 and uses thereofBIOSION INC·Filed 2021·Application pending·0 cites
- 2040US2023167182A1Antibodies binding il6r and uses thereofBIOSION INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mingjiu Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →